Steven J Wittenberger

USPTO Granted Patents = 22 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 7.6

ph-index = 8

Forward Citations = 282(Granted Patents)

Company Filing History:

19 out of 4,177

Abbott Laboratories Corporation

4. 1 out of 832,680

Other

patents

Years Active: 1994-2016

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9260411 - Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile (2016-02-16),

2. 8399468 - Octahydro-pyrrolo[3,4-B]pyrrole derivatives (2013-03-19),

3. 7538226 - (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane (2009-05-26),

4. 7365093 - Endothelin antagonists (2008-04-29),

5. 7354937 - (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane (2008-04-08),

6. 7208517 - Endothelin antagonists (2007-04-24),

7. 7074932 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2006-07-11),

8. 6946481 - Endothelin antagonists (2005-09-20),

9. 6579986 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2003-06-17),

10. 6462194 - Endothelin antagonists (2002-10-08),

11. 6437106 - Process for preparing 6-o-substituted erythromycin derivatives (2002-08-20),

12. 6417366 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2002-07-09),

13. 6380241 - Treatment of diseases using endothelin antagonists (2002-04-30),

14. 6329536 - Stereoselective process for producing nitro compounds (2001-12-11),

15. 6162927 - Endothelin antagonists (2000-12-19),

Sure, I can help with that! Here is the article about inventor Steven J Wittenberger:

Title: The Inventive Mind of Steven J Wittenberger

Introduction:

Steven J Wittenberger, a talented inventor based in Mundelein, Illinois (US), has left a mark in the field of pharmaceuticals with his innovative patents and contributions. With a total of 22 patents to his name, Wittenberger continues to push boundaries and pave the way for advancements in the industry.

Latest Patents:

1. Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile

2. Octahydro-pyrrolo[3,4-B]pyrrole derivatives

Career Highlights:

Having worked at Abbott Laboratories Corporation and Abbott Laboratories, Wittenberger has gained extensive experience in the pharmaceutical sector. His latest patents showcase his expertise in developing compounds with significant therapeutic potential.

Collaborations:

Throughout his career, Steven J Wittenberger has collaborated with esteemed professionals in the field. Some of his notable coworkers include Steven A King and Martin Winn, who have contributed to the success of various projects alongside Wittenberger.

Conclusion:

In conclusion, Steven J Wittenberger stands as a pioneer in the realm of pharmaceutical inventions, with his patented compounds holding promise for treating a range of conditions. His dedication to innovation and collaboration underscores his commitment to advancing the field and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.